Diagnosed with SMM, SPB, or MGUS?
Learn how you can stall the development of full-blown Multiple Myeloma with evidence-based nutritional and supplementation therapies.
Click the orange button to the right to learn more.
- You are here:
- Home »
- Blog »
- Pre-Myeloma »
- Progression of MGUS, SMM to Myeloma?
Progression of MGUS, SMM to Myeloma?
According to the excerpt linked below, a number of identifiable risk factors have been identified by conventional oncology. Factors that increase the risk of progression of MGUS, SMM to Myeloma.
If you are an MGUS or SMM patient, wouldn’t it be useful to have an illustrated list of evidence-based non-conventional therapies that:
- Reduce your risk of MM
- Enhance your bone mineral density (strengthen your bones)
- Explain many of the key issues related to living with pre-myeloma?
This is the Pre-MM Program- course and consultation.
The article linked below describes non-conventional therapies. Therapies that have not been studied or approved by the FDA. It is no surprise that the FDA has not studied how diet or the patient’s weight may affect his or her risk of progression of pre-myeloma to full myeloma.
As a result, conventional oncology knows little about evidence-based non-conventional therapies. If you ask your oncologist about a diet to reduce your risk of MM, he is likely to reply that you can eat anything you want. That there is no “evidence” that diet can affect a person’s risk of MM.
If you are interested in learning more about the pre-MM program email me at David.PeopleBeatingCancer@gmail.com
Thank you,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
The role of nutrition and gut microbiome in the progression of multiple myeloma and its precursor disease
“Multiple myeloma (MM) is the second most common hematological malignancy, characterized by unregulated monoclonal proliferation in the bone marrow.
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are premalignant conditions that can progress to MM.
Identifying etiological risk factors for MM and its precursor diseases is crucial for prevention.
- Obesity,
- diet,
- vitamin D levels,
- and gut microbiota alterations
have been identified as lifestyle factors affecting MM and MGUS risk. Factors that increase the risk of progression of MGUS, SMM to Myeloma
Upon disease onset, treatment strategies aim to reduce disease burden, enhance prognosis, and optimize patients’ quality of life. Nutrition and body weight have been shown to affect disease progression and treatment outcomes.
MM patients often present with
- vitamin D,
- vitamin B12,
- and folate deficiencies,
which worsen disease prognosis. High body mass index is linked to increased death rates among MM patients and an increased risk of MGUS transformation to MM. Gut microbiota has also been associated with disease progression and response to treatment.
This literature review aims to summarize the available evidence regarding the impact of nutrition and nutritional status on MM patients beyond prevention, highlighting the significance of gut microbiome and dysbiosis in MM progression.”